Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

A Single Next Generation Sequencing Assay for Detection of Driver Mutations, Translocations and Copy Number Alterations in Patients with Multiple Myeloma

Cecilia Bonolo De Campos, James B Smadbeck, Mariano Arribas, Neeraj Sharma, Gregory J Ahmann, Shaji K Kumar, A. Keith Stewart, Rafael Fonseca, P. Leif Bergsagel, Yan Asmann, Linda B. Baughn, Esteban Braggio

Blood (2022) 140 (Supplement 1): 7180–7181.

https://doi.org/10.1182/blood-2022-170749

Published: 2022

Journal Articles

Newly Diagnosed, Untreated, Multiple Myeloma (MM) Patient Samples Already Harbor Cereblon (CRBN) Exon 10 Deletions Associated with Drug Resistance

Yuan Xiao Zhu, Gregory J Ahmann, Laura Ann Bruins, Mariano Arribas, Xianfeng Chen, Marta Chesi, P. Leif Bergsagel, Rafael Fonseca, Lisa M. Rimsza

Blood (2022) 140 (Supplement 1): 4187–4188.

https://doi.org/10.1182/blood-2022-157316

Published: 2022

Journal Articles

Identifying Mechanisms Associated with Venetoclax Resistance in Multiple Myeloma (MM)

Yuan Xiao Zhu, Laura Ann Bruins, Joseph Ahmann, Cecilia Bonolo De Campos, Esteban Braggio, Xianfeng Chen, Mariano Arribas, Susie Darvish, Gregory J Ahmann, Rafael Fonseca

Blood (2021) 138 (Supplement 1): 2668.

https://doi.org/10.1182/blood-2021-153747

Published: 2021

Journal Articles

Measles, Mumps & Rubella Titers Post Autologous Stem Cell Transplant in Multiple Myeloma Patients Induced with Modern Therapy

Mariano Arribas, Gregory J Ahmann, BS, Skye Buckner-Petty, MPH, Esteban Braggio, PhD, Elitza S Theel, PhD, Rafael Fonseca, MD

Blood (2020) 136 (Supplement 1): 43.

https://doi.org/10.1182/blood-2020-142616

Published: 2020

Journal Articles

Integrative Analysis of FISH, Transcriptomics and Mutational Status Predicts Responsiveness to Novel Agents in Multiple Myeloma

Cecilia Bonolo De Campos, PhD, Caleb K Stein, PhD, Nathalie Meurice, PhD, Laura Ann Bruins, BS, Joachim L Petit, PhD, Alysia N Polito, BS, Gregory J Ahmann, BS, Shulan Tian, MS, PhD, P. Leif Bergsagel, MD, Esteban Braggio, PhD, A. Keith Stewart, MB, ChB

Blood (2019) 134 (Supplement_1): 574.

https://doi.org/10.1182/blood-2019-130977

Published: 2019

Journal Articles

Myeloma Cells Addicted to Glutamine for Biomass Production Are Sensitive to Lenalidomide

Sinto Chirackal, PhD, Esteban Braggio, PhD, Rahman Atiqur, PhD, Gregory J Ahmann, BS, Yuan Xiao Zhu, PhD, A. Keith Stewart, MB, ChB, Marta Chesi, PhD, P. Leif Bergsagel, MD, Rafael Fonseca, MD

Blood (2019) 134 (Supplement_1): 4410.

https://doi.org/10.1182/blood-2019-124967

Published: 2019

Journal Articles

PIKfyve Inhibitors for the Treatment of Multiple Myeloma

Cecilia Bonolo De Campos, PhD, Yuan Xiao Zhu, PhD, Chang-Xin Shi, PhD, Laura Ann Bruins, BS, Joachim L Petit, PhD, Alysia N Polito, BS, Meaghen E Sharik, BS, Caleb K Stein, MS, Gregory J Ahmann, BS, Ilsel D Lopez Armenta, BS, Nikolai Sepetov, PhD, Sergei Romanov, PhD, P. Leif Bergsagel, MD, Marta Chesi, PhD, Nathalie Meurice, PhD, A. Keith Stewart, MBChB, MBA

Blood (2017) 130 (Supplement 1): 4423.

https://doi.org/10.1182/blood.V130.Suppl_1.4423.4423

Published: 2017

Journal Articles

"Direct to Drug" Screening As a Route to Individualized Therapy in Multiple Myeloma

Nathalie Meurice, PhD, Joachim L Petit, PhD, Cecilia Bonolo De Campos, PhD, Alysia N Polito, BS, Ilsel D Lopez Armenta, BS, Gregory J Ahmann, BS, Laura Ann Bruins, BS, Joseph R Mikhael, MD FRCPC, MD, Craig B. Reeder, MD, Angela A Mayo, MS, PA-C, P. Leif Bergsagel, MD, Rafael Fonseca, MD, Nikolai Sepetov, PhD, Sergei Romanov, PhD, A. Keith Stewart, MBChB, MBA

Blood (2017) 130 (Supplement 1): 3080.

https://doi.org/10.1182/blood.V130.Suppl_1.3080.3080

Published: 2017

Journal Articles

Charting Venetoclax Sensitivity and Synergism Ex Vivo in Multiple Myeloma

Nathalie Meurice, PhD, Joachim L Petit, PhD, Jessica L Todsen, Cecilia Bonolo De Campos, PhD, Alysia N Polito, BS, Ilsel D Lopez Armenta, BS, Gregory J Ahmann, BS, A. Keith Stewart, MBChB, MBA

Blood (2017) 130 (Supplement 1): 3081.

https://doi.org/10.1182/blood.V130.Suppl_1.3081.3081

Published: 2017

Journal Articles

Biologic and genetic characterization of the novel amyloidogenic lambda light chain–secreting human cell lines, ALMC-1 and ALMC-2

Bonnie K. Arendt, Marina Ramirez-Alvarado, Laura A. Sikkink, Jonathan J. Keats, Gregory J. Ahmann, Angela Dispenzieri, Rafael Fonseca, Rhett P. Ketterling, Ryan A. Knudson, Erin M. Mulvihill, Renee C. Tschumper, Xiaosheng Wu, Steven R. Zeldenrust, Diane F. Jelinek

Blood (2008) 112 (5): 1931–1941.

https://doi.org/10.1182/blood-2008-03-143040

Published: 2008

Includes: Supplemental data

Journal Articles

Establishment and Characterization of an Ig Lambda Secreting Cell Line from a Patient with AL Amyloidosis.

Bonnie K. Arendt, BS, Gregory J. Ahmann, B.S., Erin M. Mulvihill, B.S., Laura A. Sikkink, B.S., Angela Dispenzieri, M.D., Marina Ramirez-Alvarado, Ph.D., Steven R. Zeldenrust, M.D.Ph.D., Rafael Fonseca, M.D., Diane F. Jelinek, Ph.D.

Blood (2006) 108 (11): 3520.

https://doi.org/10.1182/blood.V108.11.3520.3520

Published: 2006

Journal Articles

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

Natalia Gonzalez-Paz, Wee J. Chng, Rebecca F. McClure, Emily Blood, Martin M. Oken, Brian Van Ness, C. David James, Paul J. Kurtin, Kimberly Henderson, Gregory J. Ahmann, Morie Gertz, Martha Lacy, Angela Dispenzieri, Philip R. Greipp, Rafael Fonseca

Blood (2006) 109 (3): 1228–1232.

https://doi.org/10.1182/blood-2006-05-024661

Published: 2006

Journal Articles

A Comparative Analysis of Chromosome 13 Gene Expression and Copy Number Changes in Multiple Myeloma Using Array-Based Methods.

Blood (2005) 106 (11): 1557.

https://doi.org/10.1182/blood.V106.11.1557.1557

Published: 2005

Journal Articles

A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity.

Gregory J. Ahmann, Kimberly J. Henderson, Tammy L. Price-Troska, Michael M. Timm, Rempel Rachel, Roberta W. DeGoey, Christy M. Finke, Angela Dispenzieri, Philip R. Greipp, Alicia Sable-Hunt, Leif Bergsagel, Rafael Fonseca

Blood (2005) 106 (11): 3413.

https://doi.org/10.1182/blood.V106.11.3413.3413

Published: 2005

Journal Articles

The t(4;14) Is Present in Patients with Early Stage Plasma Cell Proliferative Disorders Including MGUS and Smoldering Multiple Myeloma (SMM).

Scott A. Van Wier, BS, Gregory J. Ahmann, BS, Kimberly J. Henderson, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Dirk M. Larson, Angela Dispenzieri, MD, Morie A. Gertz, MD, Robert A. Kyle, MD, Rafael Fonseca, MD

Blood (2005) 106 (11): 1545.

https://doi.org/10.1182/blood.V106.11.1545.1545

Published: 2005

Journal Articles

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS

Wee Joo Chng, Scott A. Van Wier, Gregory J. Ahmann, Jerry M. Winkler, Syed M. Jalal, Peter Leif Bergsagel, Marta Chesi, Mike C. Trendle, Martin M. Oken, Emily Blood, Kim Henderson, Rafael Santana-Dávila, Robert A. Kyle, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Philip R. Greipp, Rafael Fonseca

Blood (2005) 106 (6): 2156–2161.

https://doi.org/10.1182/blood-2005-02-0761

Published: 2005

Journal Articles

A Comprehensive Study of Chromosome 13 Abnormalities (Δ 13) in Multiple Myeloma Using High-Throughput, Array-Based Methods.

Angela S. Baker, Ph.D., Tammy Price-Troska, Michael L. Bittner, Ph.D., Scott A. Van Wier, Rachel Rempel, Gregory J. Ahmann, Tyler S. Pidgeon, Spyro Mousses, Ph.D., Bernie Futscher, Ph.D., Rafael D. Fonseca, M.D., John D. Carpten, Ph.D.

Blood (2004) 104 (11): 1417.

https://doi.org/10.1182/blood.V104.11.1417.1417

Published: 2004

Journal Articles

Clinical Implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32) and -17p13 (p53) Deletions in Myeloma Patients Treated with High Dose Therapy.

Morie Abraham Gertz, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Philip R. Greipp, MD, Mark R. Litzow, MD, Kim J. Henderson, BA, Scott A. Van Wier, BA, Gregory J. Ahmann, BA, Rafael Fonseca, MD

Blood (2004) 104 (11): 334.

https://doi.org/10.1182/blood.V104.11.334.334

Published: 2004

Journal Articles

Characterization of Waldenström Macroglobulinemia Subtypes using Global Gene Expression Profiling.

Tae-Hoon Chung, PhD, Seungchan Kim, PhD, Angela S. Baker, PhD, Tammy Price-Troska, BA, Ruifang Xu, PhD, Irene Ghobrial, MD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Morie A. Gertz, MD, Scott A. Van Wier, BA, Gregory J. Ahmann, BA, John Carpten, PhD, Rafael Fonseca, MD

Blood (2004) 104 (11): 786.

https://doi.org/10.1182/blood.V104.11.786.786

Published: 2004

Journal Articles

Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions

Roelandt F. J. Schop, W. Michael Kuehl, Scott A. Van Wier, Gregory J. Ahmann, Tammy Price-Troska, Richard J. Bailey, Syed M. Jalal, Ying Qi, Robert A. Kyle, Philip R. Greipp, Rafael Fonseca

Blood (2002) 100 (8): 2996–3001.

https://doi.org/10.1182/blood.V100.8.2996

Published: 2002

NARROW

A Single Next Generation Sequencing Assay for Detection of Driver Mutations, Translocations and Copy Number Alterations in Patients with Multiple Myeloma

Newly Diagnosed, Untreated, Multiple Myeloma (MM) Patient Samples Already Harbor Cereblon (CRBN) Exon 10 Deletions Associated with Drug Resistance

Identifying Mechanisms Associated with Venetoclax Resistance in Multiple Myeloma (MM)

Measles, Mumps & Rubella Titers Post Autologous Stem Cell Transplant in Multiple Myeloma Patients Induced with Modern Therapy

Integrative Analysis of FISH, Transcriptomics and Mutational Status Predicts Responsiveness to Novel Agents in Multiple Myeloma

Myeloma Cells Addicted to Glutamine for Biomass Production Are Sensitive to Lenalidomide

PIKfyve Inhibitors for the Treatment of Multiple Myeloma

"Direct to Drug" Screening As a Route to Individualized Therapy in Multiple Myeloma

Charting Venetoclax Sensitivity and Synergism Ex Vivo in Multiple Myeloma

Biologic and genetic characterization of the novel amyloidogenic lambda light chain–secreting human cell lines, ALMC-1 and ALMC-2

Establishment and Characterization of an Ig Lambda Secreting Cell Line from a Patient with AL Amyloidosis.

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implications

A Comparative Analysis of Chromosome 13 Gene Expression and Copy Number Changes in Multiple Myeloma Using Array-Based Methods.

A Local Versus Centralized Processing Comparison of Plasma Cell Isolation, Viability, and RNA Integrity.

The t(4;14) Is Present in Patients with Early Stage Plasma Cell Proliferative Disorders Including MGUS and Smoldering Multiple Myeloma (SMM).

A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS

A Comprehensive Study of Chromosome 13 Abnormalities (Δ 13) in Multiple Myeloma Using High-Throughput, Array-Based Methods.

Clinical Implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32) and -17p13 (p53) Deletions in Myeloma Patients Treated with High Dose Therapy.

Characterization of Waldenström Macroglobulinemia Subtypes using Global Gene Expression Profiling.

Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only